SLC6A3 and Parkinson disease: The primary objective is to comprehensively investigate how GDNF enhances cognitive function in PD mice by facilitating DAT glycosylation and membrane distribution, along with elucidating its precise mechanisms of action within the mesocortical dopaminergic neurons.